A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared to Clarityne Tablets

NCT03151720 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: loratadine (Xisimin [Test Treatment])
DRUG: loratadine (Clarityne [Reference Treatment])

Sponsor

Xian-Janssen Pharmaceutical Ltd.